|
RNCOS E-Services Pvt. Ltd.: Switchover Time - Chronic Indications to
Outdo Acute Segment in India
(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:29082008
According to "Booming Pharma Sector in India", a new market research
report by RNCOS, prevalence of chronic diseases is increasing at
alarming rates in India, and is expected to create a huge opportunity
for drug manufacturers.
The report says that market for drugs against acute indications
presently account for around 75% of the total pharmaceutical sales.
Owing to factors such as large scale prevalence of infectious diseases
and poor hygiene and sanitary conditions, the market for drugs against
acute indications will continue to dominate the overall market, but the
growth of the chronic segment is expected to far exceed that of the
acute segment.
Massive urbanization, sedentary lifestyles, growing cases of obesity,
and an increased switch over from traditional to western diets has led
to a rapid rise in the prevalence of chronic diseases in India. It's
expected that by 2015, the country will have 62 Million coronary heart
disease patients and 46 Million diabetes patients. Similarly, the
number of people suffering from depression and other neurological
disorders will also increase rapidly. This will make diabetes, cardiac
and CNS drugs the fastest growing therapy areas in the Indian
pharmaceutical market.
The RNCOS research report forecasts that the market for diabetes drugs
is expected to grow fastest amongst all therapy areas at a CAGR of 16%
between 2007 and 2011. Cardiac and CNS drugs are projected to be the
second and third fastest growing segments, posting a CAGR of 15% and
12% respectively during the same timeframe.
"Booming Pharma Sector in India" is a unique market-based research
study that provides a detailed insight and objective analysis on the
Indian pharmaceutical market. It features a thorough statistical and
analytical overview on the Indian pharmaceutical market, and provides
past, present and future data on the entire structure, composition and
working of the Indian pharmaceutical market. This study intensively
discusses the opportunities and challenges that are expected to arise
within and from the pharmaceutical market.
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. It
has a team of industry experts who analyze data collected from credible
sources. They provide industry insights and analysis that helps
corporations to take timely and accurate business decision in today's
globally competitive environment.
For more information visit: http://rncos.com/Report/IM131.htm Current
Industry News: http://www.rncos.com/Blog/
CONTACT: RNCOS
Tel: +91 11 4214 1229
Tel: +91 11 4214 1228
e-mail: info@rncos.com
WWW: http://www.rncos.com
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To TMCnet.com's Homepage ]
|
INDUSTRIES
INDUSTRIES
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, February 2-4, 2009. Miami, Florida.
